Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Integra LifeSciences Holdings Corporation stock | $67.68

Learn how to easily invest in Integra LifeSciences Holdings Corporation stock.

Integra LifeSciences Holdings Corporation is a medical devices business based in the US. Integra LifeSciences Holdings Corporation shares (IART) are listed on the NASDAQ and all prices are listed in US Dollars. Integra LifeSciences Holdings Corporation employs 3,700 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Integra LifeSciences Holdings Corporation

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IART – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Integra LifeSciences Holdings Corporation stock price (NASDAQ: IART)

Use our graph to track the performance of IART stocks over time.

Integra LifeSciences Holdings Corporation shares at a glance

Information last updated 2021-10-10.
Latest market close$67.68
52-week range$42.12 - $77.40
50-day moving average $71.46
200-day moving average $70.46
Wall St. target price$77.70
PE ratio 28.1442
Dividend yield N/A (0%)
Earnings per share (TTM) $2.41

Buy Integra LifeSciences Holdings Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Integra LifeSciences Holdings Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Integra LifeSciences Holdings Corporation price performance over time

Historical closes compared with the close of $67.68 from 2021-10-15

1 week (2021-10-08) -0.38%
1 month (2021-09-17) -2.80%
3 months (2021-07-16) 0.68%
6 months (2021-04-16) -6.33%
1 year (2020-10-16) 39.66%
2 years (2019-10-17) 9.23%
3 years (2018-10-17) 6.30%
5 years (2016-10-17) 80.75

Is Integra LifeSciences Holdings Corporation under- or over-valued?

Valuing Integra LifeSciences Holdings Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Integra LifeSciences Holdings Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Integra LifeSciences Holdings Corporation's P/E ratio

Integra LifeSciences Holdings Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Integra LifeSciences Holdings Corporation shares trade at around 28x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

Integra LifeSciences Holdings Corporation's PEG ratio

Integra LifeSciences Holdings Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5233. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Integra LifeSciences Holdings Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Integra LifeSciences Holdings Corporation's EBITDA

Integra LifeSciences Holdings Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $395.9 million.

The EBITDA is a measure of a Integra LifeSciences Holdings Corporation's overall financial performance and is widely used to measure a its profitability.

Integra LifeSciences Holdings Corporation financials

Revenue TTM $1.5 billion
Operating margin TTM 18.54%
Gross profit TTM $885.6 million
Return on assets TTM 4.92%
Return on equity TTM 14.06%
Profit margin 13.62%
Book value $18.62
Market capitalisation $5.7 billion

TTM: trailing 12 months

Shorting Integra LifeSciences Holdings Corporation shares

There are currently 4.3 million Integra LifeSciences Holdings Corporation shares held short by investors – that's known as Integra LifeSciences Holdings Corporation's "short interest". This figure is 2.9% down from 4.5 million last month.

There are a few different ways that this level of interest in shorting Integra LifeSciences Holdings Corporation shares can be evaluated.

Integra LifeSciences Holdings Corporation's "short interest ratio" (SIR)

Integra LifeSciences Holdings Corporation's "short interest ratio" (SIR) is the quantity of Integra LifeSciences Holdings Corporation shares currently shorted divided by the average quantity of Integra LifeSciences Holdings Corporation shares traded daily (recently around 387069.13470116). Integra LifeSciences Holdings Corporation's SIR currently stands at 11.21. In other words for every 100,000 Integra LifeSciences Holdings Corporation shares traded daily on the market, roughly 11210 shares are currently held short.

However Integra LifeSciences Holdings Corporation's short interest can also be evaluated against the total number of Integra LifeSciences Holdings Corporation shares, or, against the total number of tradable Integra LifeSciences Holdings Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Integra LifeSciences Holdings Corporation's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Integra LifeSciences Holdings Corporation shares in existence, roughly 50 shares are currently held short) or 0.0596% of the tradable shares (for every 100,000 tradable Integra LifeSciences Holdings Corporation shares, roughly 60 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Integra LifeSciences Holdings Corporation.

Find out more about how you can short Integra LifeSciences Holdings Corporation stock.

Integra LifeSciences Holdings Corporation share dividends

We're not expecting Integra LifeSciences Holdings Corporation to pay a dividend over the next 12 months.

Have Integra LifeSciences Holdings Corporation's shares ever split?

Integra LifeSciences Holdings Corporation's shares were split on a 2:1 basis on 3 January 2017. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Integra LifeSciences Holdings Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Integra LifeSciences Holdings Corporation shares which in turn could have impacted Integra LifeSciences Holdings Corporation's share price.

Integra LifeSciences Holdings Corporation share price volatility

Over the last 12 months, Integra LifeSciences Holdings Corporation's shares have ranged in value from as little as $42.12 up to $77.4. A popular way to gauge a stock's volatility is its "beta".

IART.US volatility(beta: 1.25)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Integra LifeSciences Holdings Corporation's is 1.246. This would suggest that Integra LifeSciences Holdings Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Integra LifeSciences Holdings Corporation overview

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, bone and joint fixation implants in the upper and lower extremities, and bone grafts products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.

Frequently asked questions

What percentage of Integra LifeSciences Holdings Corporation is owned by insiders or institutions?
Currently 14.053% of Integra LifeSciences Holdings Corporation shares are held by insiders and 90.952% by institutions.
How many people work for Integra LifeSciences Holdings Corporation?
Latest data suggests 3,700 work at Integra LifeSciences Holdings Corporation.
When does the fiscal year end for Integra LifeSciences Holdings Corporation?
Integra LifeSciences Holdings Corporation's fiscal year ends in December.
Where is Integra LifeSciences Holdings Corporation based?
Integra LifeSciences Holdings Corporation's address is: 1100 Campus Road, Princeton, NJ, United States, 08540
What is Integra LifeSciences Holdings Corporation's ISIN number?
Integra LifeSciences Holdings Corporation's international securities identification number is: US4579852082
What is Integra LifeSciences Holdings Corporation's CUSIP number?
Integra LifeSciences Holdings Corporation's Committee on Uniform Securities Identification Procedures number is: 457985109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site